Citadel Advisors’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.75M Buy
34,560
+34,464
+35,900% +$4.74M ﹤0.01% 1965
2025
Q1
$17.3K Sell
96
-10,919
-99% -$1.97M ﹤0.01% 5619
2024
Q4
$1.73M Buy
11,015
+10,919
+11,374% +$1.71M ﹤0.01% 2752
2024
Q3
$17.5K Buy
+96
New +$17.5K ﹤0.01% 5364
2024
Q2
Sell
-25,014
Closed -$4.45M 6427
2024
Q1
$4.45M Buy
25,014
+16,815
+205% +$2.99M ﹤0.01% 1839
2023
Q4
$1.02M Buy
8,199
+3,809
+87% +$473K ﹤0.01% 3013
2023
Q3
$509K Sell
4,390
-34,898
-89% -$4.05M ﹤0.01% 3745
2023
Q2
$4.61M Sell
39,288
-68,037
-63% -$7.99M ﹤0.01% 1766
2023
Q1
$8.59M Buy
107,325
+54,649
+104% +$4.38M ﹤0.01% 1414
2022
Q4
$4.17M Buy
52,676
+43,938
+503% +$3.48M ﹤0.01% 1942
2022
Q3
$609K Buy
+8,738
New +$609K ﹤0.01% 3895
2022
Q2
Sell
-8,732
Closed -$581K 6520
2022
Q1
$581K Sell
8,732
-30,013
-77% -$2M ﹤0.01% 4293
2021
Q4
$2.71M Buy
38,745
+7,742
+25% +$542K ﹤0.01% 2712
2021
Q3
$1.62M Buy
+31,003
New +$1.62M ﹤0.01% 3239
2021
Q2
Hold
0
6760
2021
Q1
Sell
-28,708
Closed -$1.72M 6575
2020
Q4
$1.72M Buy
28,708
+4,484
+19% +$269K ﹤0.01% 2712
2020
Q3
$1.04M Buy
24,224
+2,595
+12% +$112K ﹤0.01% 2881
2020
Q2
$896K Sell
21,629
-520,073
-96% -$21.5M ﹤0.01% 2953
2020
Q1
$23.4M Buy
541,702
+4,855
+0.9% +$210K 0.01% 601
2019
Q4
$29.7M Sell
536,847
-1,379
-0.3% -$76.4K 0.01% 624
2019
Q3
$18.7M Buy
538,226
+41,056
+8% +$1.43M 0.01% 839
2019
Q2
$20M Buy
497,170
+174,296
+54% +$7.02M 0.01% 804
2019
Q1
$10.6M Sell
322,874
-12,155
-4% -$400K 0.01% 1083
2018
Q4
$6.96M Buy
+335,029
New +$6.96M ﹤0.01% 1220